JOET
Virtus Terranova US Quality Momentum ETF
JOET tracks an equal-weighted index of large-cap stocks in the US displaying quality fundamental and technical attributes.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 218.3 M
ASSETS UNDER MGMT
29 bp
EXPENSES
Fund Basics
| Inception date | Nov 17, 2020 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| REGENERON PHARMACEUTICALS | 0.9 % |
| VERTIV HOLDINGS CO. CLASS A | 0.9 % |
| ACCENTURE PLC-CL A | 0.9 % |
| ELI LILLY & CO | 0.9 % |
| CHENIERE ENERGY INC | 0.9 % |
| INTERCONTINENTALEXCHANGE INC | 0.9 % |
| QUANTA SERVICES INC | 0.9 % |
| VERTEX PHARMACEUTICALS INC | 0.9 % |
| ARCH CAPITAL GROUP LTD | 0.9 % |
| PHILLIPS 66 | 0.8 % |
Constituent Breakdown
| Number of holdings | 126 |
| Herfindahl-Hirschman Index | 81 |
| Wgt avg mkt cap (mns) | $295,697 |
| Large cap (>$10bn) | 98.2% |
| Mid cap ($2-10bn) | 0.0% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 98.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.7 % |
 |
IRELAND | 3.1 % |
 |
SWITZERLAND | 1.6 % |
 |
BERMUDA | 0.9 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.2% | 4.7% | 10.6% | 17.3% | 8.8% | -- | -- | 10.8% |
| Dividend Yield | 0.0% | 0.7% | 0.7% | 1.0% | 1.0% | -- | -- | 0.8% |
| Total Returns | 7.2% | 5.4% | 11.4% | 18.4% | 9.7% | -- | -- | 11.6% | Ann. Volatility | 14.3% | 14.0% | 17.2% | 16.3% | 17.8% | -- | -- | 17.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.98 | 81% |
| MSCI EAFE | 0.69 | 61% |
| MSCI Emg Mkts | 0.42 | 58% |
Liquidity Measures
| Avg. volume (000) | 24 |
| ADV traded (mns) | $1 |
| Turnover | 0.5% |
| Avg. Bid/Ask (% of price) | 0.13% |
Technical Indicators
| 30d moving avg. (EMA) | $45.49 |
| Relative strength (RSI) | 48 |
| MACD/Signal | -0.05/-0.03 |
| Bollinger Bands (Upper/Lower) | $46.30/$44.73 |
| Short interest (% of AUM) | 1.5% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. JOET |
Expenses vs. JOET |
ALTAR Score™ vs. JOET |
|---|---|---|---|---|
| FTC | First Trust Large Cap Growth AlphaDEX Fund | 41.5% | +29 bp | -2.6% |
| ROUS | Hartford Multifactor US Equity ETF | 37.3% | -10 bp | +1.3% |
| QUS | State Street SPDR MSCI USA StrategicFactors ETF | 33.9% | -14 bp | -0.2% |
| XOEF | iShares S&P 500 ex S&P 100 ETF | 33.8% | -9 bp | +0.1% |
| JMOM | JPMorgan U.S. Momentum Factor ETF | 33.7% | -17 bp | -1.1% |
| USMV | iShares MSCI USA Min Vol Factor ETF | 33.4% | -14 bp | 0.0% |
| ESMV | iShares ESG MSCI USA Min Vol Factor ETF | 33.0% | -11 bp | -0.2% |
| JQUA | JPMorgan U.S. Quality Factor ETF | 32.5% | -17 bp | +0.2% |
| ROE | Astoria US Quality Kings ETF | 31.5% | +20 bp | +1.2% |
| DSPY | Tema S&P 500 Historical Weight ETF | 31.4% | -11 bp | -0.3% |
Risk and Returns: JOET vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.9%
ALTAR SCORE™
54th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. JOET's ALTAR Score™ is approximately 0.1 standard
deviations above the category average. This places JOET in the 54th percentile
among funds in the category.
Sell-Side Consensus
$53.01
PRICE TARGET
+23.0%
UPSIDE